반응식
[CH3:1][S:2]([C:5]1[CH:28]=[CH:27][C:8](/[CH:9]=[C:10]2/[C:11]([CH3:26])=[C:12]([CH2:22][C:23](O)=[O:24])[C:13]3[C:18]/2=[CH:17][CH:16]=[C:15]([N:19]([CH3:21])[CH3:20])[CH:14]=3)=[CH:7][CH:6]=1)(=[O:4])=[O:3].C(Cl)(=O)C([Cl:32])=O>C1COCC1>[CH3:1][S:2]([C:5]1[CH:28]=[CH:27][C:8](/[CH:9]=[C:10]2/[C:11]([CH3:26])=[C:12]([CH2:22][C:23]([Cl:32])=[O:24])[C:13]3[C:18]/2=[CH:17][CH:16]=[C:15]([N:19]([CH3:21])[CH3:20])[CH:14]=3)=[CH:7][CH:6]=1)(=[O:4])=[O:3]참가 물질
4
실험 절차
(Z)-1-(p-methylsulfonylbenzylidene)-5-dimethylamino-2-methyl-3-indenylacetic acid (70 mmol) in THF (500 ml) is allowed to react with oxalylchloride (2 M in CH2Cl2 ; 70 mmol) under reflux conditions (24 hours). The solvent is evaporated to yield the title compound, which is used as such in the next step.
후처리
- customThe solvent is evaporated
출처 및 근거
- ORD 기록
- ord-e2929b27588e4b1888b43b4c40832e59
- 출처 데이터셋
- uspto-grants-2000_02
- 특허 번호
- US06028116
연결된 노트
불러오는 중…